# Variance of HRD From Paired Ovarian Cancer

> **NCT05069818** · — · UNKNOWN · sponsor: **Xiaoxiang Chen** · enrollment: 50 (estimated)

## Conditions studied

- Ovarian Cancer
- HRD
- Platinum-sensitive Ovarian Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05069818
- **Lead sponsor:** Xiaoxiang Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069818, "Variance of HRD From Paired Ovarian Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05069818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*